|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Critical Care Medicine, St. John's Mercy Medical Center, St. Louis, MO.
Correspondence to: Jerome E. Holliday, PhD, VA Medical Center, Medicine Service 111-JC, 915 N Grand Blvd, St. Louis, MO 63106
| Abstract |
|---|
|
|
|---|
Objective: To test the hypothesis that the underlying mechanism of biofeedback ventilator weaning was the reduction of neural respiratory drive (NRD).
Design: Prospective, linear regression analysis.
Setting: Critical care medicine department in tertiary health care hospital.
Subjects: Fifteen healthy adult volunteers were randomly assigned to the biofeedback group, and 15 healthy adult volunteers were randomly assigned to a control group.
Interventions: Relaxation feedback was administered while a single variable, PaCO2, was inputted to the respiratory control system and the output measured. While rebreathing 7% CO2/93% O2, the biofeedback group received a baseline session and a relaxation feedback session and the control group received a baseline session and a no feedback session.
Measurements and results: During relaxation feedback, there
was a significant (p < 0.001 to p < 0.05) reduction in the slope
of minute ventilation (
I), mean inspiratory flow
(VT/TI), occlusion pressure in 0.1 s from
onset of inspiration (P100), respiration rate (RR), and
diaphragm (DA) EMG compared to baseline. We also found the above
breathing parameters decreased significantly for relaxation feedback
(p < 0.0010.05), compared to baseline, at maximum end-tidal
CO2 (64 ± 1.2 mm Hg) (all data are expressed as mean
± SE). The decrease for
I = -4.65 ± 1.17
L/min, DA EMG = -0.4 ± 0.21 µV,
P100 = -1.13 ± 0.56 cm H2O,
VT/TI = -144 ± 82.91 ml/s,
and RR = -3.1 ± 0.79 breaths/min. No significant changes
occurred in these parameters for the control group.
Conclusions: We conclude that the addition of the behavioral input of relaxation feedback results in decreasing the values of respiratory parameters that reflect NRD.
Key Words: biofeedback CO2 rebreathing neural respiratory drive respiration
| Introduction |
|---|
|
|
|---|
I) during CO2 rebreathing. A depressed drive has also been implicated in failure to wean. Haake et al11 reported that a ventilator patient who failed weaning had a depressed central drive manifested by hypopnea with increasing PaCO2. Thus, difficulty with weaning could be due to either failure to maintain blood gases due to decreased drive, problems with lung function or muscle strength, or due to respiratory distress where high drive is involved. The present study focuses on the latter.
To determine the effect of biofeedback on NRD, we studied the effects
of biofeedback during CO2 rebreathing. We
hypothesized that during hypercapnic challenge, relaxation feedback
would reduce values of ventilatory parameters
I,
P100, mean inspiratory flow
(VT/TI), and diaphragm (DA)
electromyogram (EMG) which reflect NRD.
| Materials and Methods |
|---|
|
|
|---|
Since the relaxation feedback required the subjects' eyes be opened to receive the visual feedback,7 the present study would have to be performed with eyes opened for both baseline and relaxation feedback sessions. A subgroup of the study population underwent an additional study to assess the effect of eyes open and eyes closed on CO2 rebreathing. With these tests, we could directly compare our results with the previous studies of Bulow8 and Wolkove and coworkers,9 whose subjects had their eyes closed. Twelve of our 30 subjects volunteered for a separate study to redo Asmussen's10 work. Each volunteer had two sessions of rebreathing CO2 with the second session following directly after the first. During the first CO2 rebreathing session, the eyes were opened, and during the second session, the subjects' eyes were closed. To control for the relaxation variable, during the eyes-closed session, the subjects were told not to relax but to try to stay awake, a maneuver used by Shea and coworkers.12
A schematic drawing of the hypercapnic challenge (Read13 ) breathing circuit showing the CO2 rebreathing bag, the biofeedback system, and the two-way valve with balloon for occluding the airway for P100 measurements (Hans Rudolph; Kansas City, MO; model 9326) is shown in Figure 1 . To prevent subjects from consciously controlling P100, the valve opening the balloon was placed in a soundproof container. The P100 was measured every 20 seconds during CO2 rebreathing (approximately every third or fourth breath). Tidal volume (VT) was measured by integrating the output of a heated pneumotach (Hans Rudolph model 3700) that was calibrated before each session. The output of the pneumotach was fed into a computer that performed the integration.
|
Each subject sat in a comfortable chair and breathed room air through a
mouthpiece until end-tidal CO2
(ETCO2) concentration reached a steady state and
the subject was accustomed to breathing through the mouthpiece. The
ETCO2 was measured with an infrared monitor
(Puritan Bennett Datex No 125; Los Angeles, CA) which was calibrated
before each session. A 5-L rebreathing bag was used to ensure rapid
mixing of gas between the bag and lungs at the onset of rebreathing.
The subjects in each group received two 3-min sessions of rebreathing
7% CO2/93% O2. The mean
ETCO2 at the start was 48 ± 0.86 mm Hg and
increased after 3 minutes of rebreathing CO2 to
64 ± 1.2 mm Hg. The mean increase of 16 mm Hg in
ETCO2 is considered adequate for stimulating
respiratory drive. The rate of increase of ETCO2
was 5.19 mm Hg/min, which was within the limits considered satisfactory
by Read13
(36 mm Hg/min). In addition to
ETCO2, the respiratory parameters measured during
each hypercapnic challenge in both groups were VT,
I, P100,
VT/TI, respiration rate (RR), DA EMG, heart
rate (HR), and O2 saturation (pulse oximeter
model 3700; Ohmeda). The data were recorded on computer and on an
audiotape by a FM recording adapter (A. R. Vetter Co.; Rebersburg,
PA; model 3) and recorded on 6-channel Dynograph recorder
(Sensormedics; CA; model R611). The P100 was
obtained from the Dynograph recorder of occlusion pressure as a
function of time.
The pre- and post-CO2 rebreathing measurements of the above-mentioned breathing parameters were taken while the subjects were breathing room air (21% O2) for 5 minutes. This was done to show that the parameters reflecting NRD of the two groups were within normal limits and returned to normal value after CO2 rebreathing. After each session, the subject completed two Borg scales. The first was the Borg scale15 for measuring shortness of breath (SOB), and the second, a modified Borg scale for measuring anxiety.
The first CO2 rebreathing session served as a CO2 baseline for both groups. In the second CO2 rebreathing session, the biofeedback group was taught to passively relax their chest muscles (an important maneuver in biofeedback control) at the same time they received visual feedback (a line displayed on the computer monitor) and auditory feedback (a sound heard from the speaker) from EMG measurements from the 3rd IC muscles (Fig 1) . The sound was heard whenever the line went above threshold line T, a point of reference that was initially set at a level slightly below their resting background muscle tension (BK) EMG (Fig 2 ).
|
The slope of each respiratory parameter, as a function of ETCO2, was determined by the method of least squares. The differences between baseline and the relaxation feedback session in the biofeedback group and the baseline and no FB sessions in the control group were compared for significance with a paired t test. All differences were considered significant at p < 0.05.
| Results |
|---|
|
|
|---|

I/
ETCO2 was
1.92 ± 0.08, and at maximum ETCO2 of 64 mm Hg
I was 28.87 ± 3.8 L/min and RR was
14.42 ± 1.73. With eyes closed,

I/
ETCO2 was
1.90 ± 0.07,
I was 33.14 ± 3.59 L/min, and RR
was 14.79 ± 1.63 at 64 mm Hg. Although a 15 percent increase in
I occurred for eyes closed, as compared to eyes
open, none of the above changes were statistically significant. There
were also no significant changes in
P100/
ETCO2 or for
P100 at 64 mm Hg between eyes open and eyes
closed. The results of the pilot study allow comparisons with the
studies of Bulow8
and Wolkove and coworkers.9
The mean baseline value of P100 for breathing
room air for the biofeedback group was 1.64
cm H2O,16
and this was in close
agreement with the control group's mean P100
value of 1.47 cm H2O. This shows the
reproducibility of the P100 data. In addition,
for the pre- and postbaseline breathing room air there was no
significant difference in
I, DA EMG,
P100, VT/TI,
and RR, showing that room air baseline measurements are stable
reference values. The validity of the diaphragm EMG is shown by the
plot of VT as a function of diaphragm EMG, for a typical
subject, in Figure 3
. The least-squares plot shows the VT increasing with the
diaphragm EMG. An unpaired t test for possible intertest
difference between the biofeedback and control groups is shown in Table 1 . There were no significant differences between the baselines of the two
groups, indicating no intertest differences.
|
|

I/
ETCO2,
DA
EMG/
ETCO2,
P100/
ETCO2,

I/TT/
ETCO2,
VT/
ETCO2, and
RR/
ETCO2 slopes for
CO2 rebreathing between baseline and relaxation
feedback (the biofeedback group) and baseline and no FB session (the
control group). There was a significant (p < 0.001 to p < 0.05)
reduction in the slopes of

I/
ETCO2,
DA
EMG/
ETCO2, and
P100/
ETCO2,
VT/TI/
ETCO2,
RR/
ETCO2 with CO2
rebreathing between baseline and relaxation feedback. No significant
differences appeared in the mean slopes of these breathing parameters
between baseline and no FB sessions for the control group. The slope
reductions (composite linear regression curves for the 15 biofeedback
subjects) for
I, VT/TI,
P100, and diaphragm EMG as a function of
ETCO2 for baseline compared to biofeedback
sessions can be seen on the four plots in Figure 4
. The points are the mean values of the 15 biofeedback subjects between
44 ± 0.56 mm Hg ETCO2 and 64 ± 1.2 mm Hg
ETCO2. The curves show a linear plot from
48 ± 0.9, the value of ETCO2 for the mixed
venous plateau, and ETCO2 of 64 ± 1.2 mm Hg.
The vertical lines at each point show the SE.
|
|
I, DA EMG,
P100, VT/TI, and RR
during relaxation feedback compared to baseline at maximum
ETCO2 (64 ± 1.2 mm Hg) as shown in Table 3
and Figure 4
. The significant reduction in RR, but the lack of any for
VT, shows that the significant reduction in
I is due to a reduction in RR and not due to
reduction in VT. The reductions in
I of
- 4.65 ± 1.17 L/min, DA EMG of - 0.4 ± 0.21 µV,
P100 of - 1.13 ± 0.56
cm H2O, VT/TI of
- 144 ± 82.91 ml/s, and in RR of - 3.1 ± 0.79 breaths/min,
reflecting NRD, shows clinical significance as well as mathematical
significance. No significant change occurred for the control group
between baseline and no FB sessions in the above parameters at maximum
ETCO2; therefore, these results show that
relaxation feedback is reducing the subjects'
I, DA
EMG VT/TI, and P100
(which reflect NRD) response to CO2. In addition,
these results show that this decrease is not due to reduced
responsiveness to CO2 the second time it is
rebreathed; in other words, there is no practice effect.
|
|
| Discussion |
|---|
|
|
|---|
The ventilatory CO2 response curves in Figure 4
and Table 2
are shifted to the right, and there is a flattening of the
slope similar to those seen in previous studies.8
9
The
18% reduction in the mean value of
I for the
relaxation feedback (Table 3)
is close to the reduction reported by
Bulow8
for the drowsy state and to the reductions reported
by Wolkove and coworkers9
for the meditative state. The
control group showed no significant change in parameters reflecting NRD
between baseline and no FB CO2 rebreathing.
During relaxation feedback, there was a significant reduction in HR,
self report of anxiety, and SOB compared to baseline (Table 4)
which
did not occur for the control group. The lack of a significant change
in multiple parameters of NRD during CO2
rebreathing between eyes open and eyes closed in the subgroup study
shows that the reduction in ventilatory response to
CO2, reported by Asmussen10
does not
appear to be due to merely closing the eyes.
One of the possible errors in this type of research is the reproducibility of repeated measurements of CO2 rebreathing. The data in Table 3 shows that there was no significant difference between baseline and no FB sessions in the control group, and there was no significant difference between the CO2 baselines of the biofeedback group and the control group (Table 1) . This shows the reproducibility of mean values during CO2 rebreathing.
Several studies have demonstrated decreased ventilator-weaning time in patients receiving biofeedback.7 21 22 23 Two breathing parameters whose reduction during biofeedback is associated with reduced ventilator-weaning time and reflects NRD are P100 and RR. Holliday and coworkers23 reported significant reductions in P100 and RR for high-drive ventilator patients between start of weaning and successful extubation using relaxation feedback. It was indicated above that several investigators1 2 3 reported that weaning was not successful when P100 was > 4 cm H2O. Yang and Tobin24 have found that RR is one of the best indicators of successful extubation. They have shown that if the ratio of RR/VT is < 100 there is a high likelihood of weaning, whereas a RR/VT > 100 indicates a poor chance of ventilator weaning. Table 3 shows that there are significant reductions in P100 and RR (without any significant reduction in VT) during CO2 rebreathing with relaxation feedback. Thus, the reduction in ventilator-weaning time with biofeedback training of ventilator patients appears to be related to the reduction of NRD. However, the present research study will have to be performed on ventilator patients before the statement can be made conclusively.
How does relaxation feedback reduce respiratory drive? In a review article, Shea25 presents the idea that there is a behavioral and an autonomic respiratory drive. Research in biofeedback has shown that what was thought to be purely autonomic phenomena could be controlled behaviorally if information about the phenomena to be controlled was fed back to the subject. Leitner and coworkers26 reported a reduction in VT, VT/TI, and peak airway pressure during loaded breathing with distraction using auditory tones. Gallego and Perruchet27 observed that humans exposed to eight pairings of sound and a brief hypoxic challenge altered their breath duration on subsequent trials with exposure to the sound alone. Since studies by Whitelaw and coworkers4 indicate that P100 is not consciously controlled, the significant reduction of P100 by biofeedback (Table 3) supports the contention that biofeedback can modify the autonomic drive.
Shea25
states that the reticular activating system (RAS)
has significant effects on the brainstem respiratory complex. Activity
in the RAS increases with arousal and can provide stimulatory effects
on certain brainstem-related neurons. Shea25
points out
that signs of increased arousal include an increase in sympathetic
nervous system activity and EEG activation. Sensory stimulation is
accompanied by increases in
I, RR, slight increases
in HR, BP, and EEG activation.28
In contrast, a reduction
from an aroused state, such as relaxation, should have the opposite
effect on the RAS, which is what the present research indicates. The
study shows that during CO2 rebreathing
relaxation feedback reduces ventilatory responses that reflect NRD.
There are also significant reductions in HR and in feelings of anxiety
and SOB for relaxation feedback CO2 rebreathing
compared to baseline CO2 rebreathing (Table 4)
which could result in reduced RAS activity. A great amount of research
has been done to show that muscle fatigue is an important factor in
ventilator-weaning failure. However, little attention has been paid to
the influence of the brainstem and RAS on setting NRD. Biofeedback may
reprogram the brainstem to reduce high NRD and facilitate weaning.
In summary, the above results show that relaxation feedback can reduce breathing parameters that reflect NRD. The reduction in NRD may be the underlying mechanism for biofeedback reducing ventilator-weaning time,7 but further studies on relaxation feedback and NRD on ventilator patients are required. The study suggests the existence of behavioral modulation of the hypercapnic ventilatory response that may be of practical utility in ventilator weaning.
| Acknowledgements |
|---|
| Footnotes |
|---|
I = inspired minute
ventilation; VT/TI = mean
inspiration flow; VT = tidal volume; µV = microvolt Received for publication April 6, 1998. Accepted for publication December 24, 1998.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. E. Holliday and M. Lippmann Reduction in Ventilatory Response to CO2 With Relaxation Feedback During CO2 Rebreathing for Ventilator Patients Chest, October 1, 2003; 124(4): 1500 - 1511. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |